1. Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis
   Chunrui Bo et al, 2021, Scientific Reports CrossRef
2. A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis
   Soudeh Ghafouri-Fard et al, 2021, International Journal of Molecular Sciences CrossRef
3. Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
   Shuang Li et al, 2019, PLOS ONE CrossRef
4. Construction of miRNA-regulated drug-pathway network to screen drug repurposing candidates for multiple sclerosis
   Xiaotong Kong et al, 2022, Medicine CrossRef
5. Uncovering potential lncRNAs and nearby mRNAs in systemic lupus erythematosus from the Gene Expression Omnibus dataset
   Haiyu Cao et al, 2019, Epigenomics CrossRef
6. MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cells
   Hengxiao Lu et al, 2021, Cytotechnology CrossRef
7. Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
   Shuang Li et al, 2021, Journal of Translational Medicine CrossRef
8. MicroRNA-653 Inhibits Thymocyte Proliferation and Induces Thymocyte Apoptosis in Mice with Autoimmune Myasthenia Gravis by Downregulating TRIM9
   Yu-Ling Cao et al, 2019, Neuroimmunomodulation CrossRef
9. Global pathway view analysis of microRNA clusters in myasthenia gravis
   Chunrui Bo et al, 2019, Molecular Medicine Reports CrossRef
10. Plasma exosomal miR‐106a‐5p expression in myasthenia gravis
    Hongyan Xu et al, 2020, Muscle & Nerve CrossRef
11. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review
    Amene Saghazadeh et al, 2022, International Immunopharmacology CrossRef
12. The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment
    Benqiao Wang et al, 2024, Frontiers in Immunology CrossRef
13. Multiple genetic factors affecting the pharmacokinetic and pharmacodynamic processes of tacrolimus in Chinese myasthenia gravis patients
    Huan-Yu Meng et al, 2020, European Journal of Clinical Pharmacology CrossRef